Dahl K, Toubro S, Dey S, Duque do Vale R, et al. Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study. Lancet 2025;406:149-162.
PMID: 40550231